Clinical Trials Logo

Hemodynamic Rebound clinical trials

View clinical trials related to Hemodynamic Rebound.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05133375 Completed - Hemodynamic Rebound Clinical Trials

Hemodynamic Changes of Tracheal Intubation With McCoy and Macintosh Laryngoscopes

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

A total of 272 patients were randomly allocated into two groups, Patients in group A were treated with Macintosh laryngoscope and in groups B with McCoy laryngoscope was used for endotracheal intubation. Pulse and systolic blood pressure was recorded by non-invasive measures before laryngoscopy and at 30 seconds, 2 and 3minutes after intubation. All this information was recorded on a Pro forma.

NCT ID: NCT03839186 Completed - Drug Reaction Clinical Trials

Pharmacogenetics Study on the Effects of Anesthetic Drugs on Circulatory Function

Start date: August 2016
Phase:
Study type: Observational

This study intends to study the effects of anesthetics on Circulatory Function Genomics and find the anesthetic effects in pharmacodynamics, pharmacokinetics, drug receptor or target DNA level differences, further guiding individual treatment in clinic, promoting the development of precision the medicine.The anesthesia medication during perioperative period is more and more accurate,reasonable and safe, so as to improve the satisfaction of the patients and their families in the perioperative period, to ensure the safety of patients.

NCT ID: NCT03168126 Completed - Fluid Overload Clinical Trials

Advanced Hemodynamic Monitoring in Free Flap Surgery

AHM
Start date: January 2014
Phase: N/A
Study type: Observational

Background: Anesthesia in free flap surgery is challenging. Monitoring of hemodynamic changes and their influence on the cardiovascular system in permanent feedback loops allow control, which is what anesthesiologists aim for to ensure an adequate blood flow and tissue oxygenation. The circulatory support and inferable volume administration are managed via heart rate (HR) and mean arterial pressure (MAP), but both parameters are influenced by variable components and are thus unfavorable for volume management. The aim of this study was to evaluate whether volume requirement may be assumable to additional monitoring parameters. Methods: 31 patients were enrolled prospectively. HR, MAP, central venous pressure and O2 saturation were comprehended based on the protocols. We expanded the data set by a permanent blinded intraoperative monitoring with registration of the Cardiac Index (CI) and Stroke Volume Variation (SVV) and semi-invasive pulse-contour analysis utilizing the Pro-AQT-Device.